Bismuth subsalicylate
Helidac (bismuth subsalicylate) is a small molecule pharmaceutical. Bismuth subsalicylate was first approved as Helidac on 1996-08-15. It is used to treat bacillary dysentery, diarrhea, dyspepsia, escherichia coli infections, and helicobacter infections amongst others in the USA.
| Trade Name | Helidac |
|---|---|
| Common Name | Bismuth subsalicylate |
| Indication | bacillary dysentery, diarrhea, dyspepsia, escherichia coli infections, helicobacter infections, nausea, stomach diseases, virus diseases |
| Drug Class | Anti-inflammatory agents (salicylic acid derivatives) |
